• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643712)   Today's Articles (1)   Subscriber (50630)
For: Sharma OP, Weinbauer GF, Behre HM, Nieschlag E. The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate. Urol Res 1992;20:317-21. [PMID: 1455564 DOI: 10.1007/bf00922743] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Number Cited by Other Article(s)
1
Challa AA, Calaway AC, Cullen J, Garcia J, Desai N, Weintraub NL, Deswal A, Kutty S, Vallakati A, Addison D, Baliga R, Campbell CM, Guha A. Cardiovascular Toxicities of Androgen Deprivation Therapy. Curr Treat Options Oncol 2021;22:47. [PMID: 33866442 PMCID: PMC8053026 DOI: 10.1007/s11864-021-00846-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/16/2021] [Indexed: 02/02/2023]
2
Estrus Suppression in Dogs. Vet Clin North Am Small Anim Pract 2018;48:595-603. [DOI: 10.1016/j.cvsm.2018.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
3
GnRH Antagonist: a New and an Effective Way of Treatment of Advanced Prostate Cancer. Indian J Surg Oncol 2017;8:385-388. [DOI: 10.1007/s13193-016-0611-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2016] [Accepted: 11/18/2016] [Indexed: 10/20/2022]  Open
4
Rick FG, Block NL, Schally AV. An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer. Onco Targets Ther 2013;6:391-402. [PMID: 23620672 PMCID: PMC3633549 DOI: 10.2147/ott.s32426] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]  Open
5
Gobello C. Effects of GnRH Antagonists vs Agonists in Domestic Carnivores, a Review. Reprod Domest Anim 2012;47 Suppl 6:373-6. [DOI: 10.1111/rda.12025] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2012] [Accepted: 07/05/2012] [Indexed: 11/27/2022]
6
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists. Prostate Cancer Prostatic Dis 2012;16:7-15. [PMID: 22751146 DOI: 10.1038/pcan.2012.25] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
7
Van Poppel H, Klotz L. Gonadotropin-releasing hormone: an update review of the antagonists versus agonists. Int J Urol 2012;19:594-601. [PMID: 22416801 DOI: 10.1111/j.1442-2042.2012.02997.x] [Citation(s) in RCA: 79] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
8
Boccon-Gibod L. An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer. Ther Adv Urol 2011;3:127-40. [PMID: 21904569 PMCID: PMC3159401 DOI: 10.1177/1756287211414457] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]  Open
9
Effect of a GnRH antagonist on GnRH agonist–implanted anestrous bitches. Theriogenology 2009;72:926-9. [DOI: 10.1016/j.theriogenology.2009.06.011] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2009] [Revised: 06/08/2009] [Accepted: 06/11/2009] [Indexed: 10/20/2022]
10
Kostanski JW, Dani BA, Reynolds GA, Bowers CY, DeLuca PP. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles. AAPS PharmSciTech 2000;1:E27. [PMID: 14727892 PMCID: PMC2750451 DOI: 10.1208/pt010427] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
11
Kostanski JW, Dani BA, Schrier B, DeLuca PP. Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats. Pharm Res 2000;17:445-50. [PMID: 10870989 DOI: 10.1023/a:1007581004844] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
12
Weinbauer GF, Nieschlag E. LH-RH antagonists: state of the art and future perspectives. Recent Results Cancer Res 1992;124:113-36. [PMID: 1615215 DOI: 10.1007/978-88-470-2186-0_11] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA